Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T08:05:30.891Z Has data issue: false hasContentIssue false

Tardive Dyskinesia and Depot Fluphenazine

Published online by Cambridge University Press:  29 January 2018

David Wiles*
Affiliation:
Department of Psychiatry, University of Oxford, Littlemore Hospital Research Unit, Littlemore Hospital, Oxford OX4 4XN
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1979 

References

Nasrallah, H. A., Rivera-Calimlim, L., Rogol, A., Gillen, J. C. & Wyatt, R. J. (1978) Fluphenazine decanoate: plasma concentrations and clinical response. Psychopharmacology Bulletin, 14, 46–7.Google ScholarPubMed
Wiles, D. H. & Franklin, M. (1978) Radioimmunoassay for fluphenazine in human plasma. British Journal of Clinical Pharmacology, 5, 265–8.CrossRefGoogle ScholarPubMed
Wiles, D. H. & Gelder, M. G. (1979) Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate. British Journal of Clinical Pharmacology (accepted for publication).CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.